Page last updated: 2024-10-24

regulation of mitochondrial translation

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA in a mitochondrion. [GOC:mah]

Mitochondrial translation is a highly regulated process that ensures the precise synthesis of proteins essential for the function of this organelle. This process is distinct from cytoplasmic translation and involves a specialized set of ribosomes, tRNAs, and translation factors. The regulation of mitochondrial translation is crucial for maintaining cellular energy production, cell growth, and survival.

**Key Regulatory Mechanisms:**

1. **Transcriptional Regulation:**
- The expression of mitochondrial DNA (mtDNA) genes encoding mitochondrial proteins is tightly regulated by nuclear transcription factors. These factors bind to specific promoter regions of mtDNA genes and control their transcription levels.
- Factors like nuclear respiratory factor 1 (NRF1), nuclear respiratory factor 2 (NRF2), and mitochondrial transcription factor A (TFAM) are involved in regulating mtDNA transcription.

2. **Translation Initiation:**
- The initiation of mitochondrial translation is a critical step regulated by several factors:
- **Mitochondrial initiation factors (mtIFs):** These factors play crucial roles in the assembly of the translation initiation complex, bringing together the small ribosomal subunit, initiator tRNA, and mRNA.
- **mRNA secondary structure:** The 5' untranslated region (UTR) of mitochondrial mRNAs often contains complex secondary structures that can regulate translation initiation.
- **Iron-sulfur cluster biogenesis:** The synthesis of iron-sulfur clusters, essential for the function of many mitochondrial proteins, can influence the efficiency of translation initiation.

3. **Translation Elongation:**
- The elongation phase of translation involves the stepwise addition of amino acids to the growing polypeptide chain.
- **Mitochondrial elongation factors (mtEFs):** These factors facilitate the movement of tRNAs along the mRNA and the peptide bond formation.
- **Aminoacyl-tRNA synthetases:** These enzymes ensure the correct attachment of amino acids to their corresponding tRNAs.

4. **Translation Termination and Ribosome Recycling:**
- Termination of translation occurs when a stop codon is encountered in the mRNA.
- **Mitochondrial release factors (mtRFs):** These factors recognize stop codons and facilitate the release of the newly synthesized protein from the ribosome.
- **Ribosome recycling factors:** These factors disassemble the ribosome and prepare it for a new round of translation.

5. **Post-translational Modifications:**
- After translation, mitochondrial proteins undergo a series of post-translational modifications, including:
- **Folding and assembly:** Proteins are correctly folded and assembled into functional complexes.
- **Import into mitochondria:** Newly synthesized proteins are transported into the mitochondria through specific import machinery.
- **Cleavage and processing:** Some mitochondrial proteins undergo proteolytic cleavage to generate mature forms.

**Factors Influencing Mitochondrial Translation:**

- **Cellular energy status:** The availability of ATP and other energy sources can influence the rate of mitochondrial translation.
- **Oxygen levels:** Oxygen is essential for oxidative phosphorylation, the primary function of mitochondria. Oxygen depletion can lead to a decrease in mitochondrial translation.
- **Stress signals:** Environmental stresses such as heat shock, oxidative stress, and nutrient deprivation can also regulate mitochondrial translation.
- **Hormonal signals:** Hormones like insulin and thyroid hormone can influence mitochondrial translation.

**Disruption of Mitochondrial Translation:**

- **Mutations in mtDNA genes:** Mutations in genes encoding mitochondrial ribosomal proteins, tRNAs, or translation factors can impair mitochondrial translation.
- **Defects in mitochondrial import machinery:** Defects in the import of nuclear-encoded proteins into mitochondria can disrupt mitochondrial translation.
- **Environmental toxins:** Some environmental toxins can inhibit mitochondrial translation.

**Consequences of Impaired Mitochondrial Translation:**

- **Reduced energy production:** Impairment of mitochondrial translation can lead to a decrease in the synthesis of proteins essential for oxidative phosphorylation, resulting in reduced ATP production.
- **Mitochondrial dysfunction:** Impaired mitochondrial translation can lead to various mitochondrial defects, including oxidative stress, apoptosis, and cell death.
- **Human diseases:** Numerous human diseases, including mitochondrial disorders, neurodegenerative diseases, and cancer, are associated with defects in mitochondrial translation.

**Regulation of mitochondrial translation is a complex and intricate process involving multiple layers of control. This precise regulation ensures the proper function of mitochondria, which are essential for cellular energy production and survival.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Serine hydroxymethyltransferase, mitochondrialA serine hydroxymethyltransferase, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:P34897]Homo sapiens (human)

Compounds (9)

CompoundDefinitionClassesRoles
oxaprozinoxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.

Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
1,3-oxazoles;
monocarboxylic acid
analgesic;
non-steroidal anti-inflammatory drug
papaverinepapaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.

Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
benzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines
antispasmodic drug;
vasodilator agent
primaquineprimaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
aminoquinoline;
aromatic ether;
N-substituted diamine
antimalarial
flupirtineflupirtine: RN given refers to parent cpd without isomeric designationaminopyridine
duloxetineduloxetine
N-[7-(2-furanyl)-5-oxo-7,8-dihydro-6H-quinazolin-2-yl]acetamidequinazolines
pyrviniumpyrvinium : A quinolinium ion that is 1-methylquinolinium substituted by dimethylamino group at position 6 and a (E)-2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl at position 2. It is a anthelminthic drug active against pinworms. The salts of pyrvinium can also be used as anticancer agents.

pyrvinium: RN given refers to parent cpd; synonyms vanquin & vankin refer to pamoate[2:1]; structure in Merck Index, 9th ed, #7810
quinolinium ionanthelminthic drug;
antineoplastic agent
2-(2-furanylmethyl)-3-[[2-(3-pyridinyl)-3H-benzimidazol-5-yl]amino]-3H-isoindol-1-oneisoindoles
gw2974GW2974: quinazoline derivative, which is able to block the activation of both the EGFR and erbB2pyridopyrimidine